Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Risk Factors for Recurrence of Hepatocellular Carcinoma After Radiofrequency Ablation

NCT01520779 is registered in ClinicalTrials.gov with Ain Shams University as lead sponsor.

NCT NCT01520779
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01520779 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Risk Factors for Recurrence of Hepatocellular Carcinoma After Radiofrequency Ablation
Lead sponsor
Ain Shams University
Phase
Observational
Overall status
Completed
Start date
January 31, 2012
Completion date
December 31, 2012
Enrollment
99 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

hepatocellular carcinoma